Integrity Alliance LLC. Buys Shares of 3,967 Veeva Systems Inc. $VEEV

Integrity Alliance LLC. purchased a new stake in shares of Veeva Systems Inc. (NYSE:VEEV) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,967 shares of the technology company’s stock, valued at approximately $886,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Kestra Investment Management LLC increased its position in shares of Veeva Systems by 2.8% during the fourth quarter. Kestra Investment Management LLC now owns 4,357 shares of the technology company’s stock valued at $973,000 after acquiring an additional 118 shares in the last quarter. Allstate Corp increased its position in shares of Veeva Systems by 101.8% during the fourth quarter. Allstate Corp now owns 11,827 shares of the technology company’s stock valued at $2,640,000 after acquiring an additional 5,965 shares in the last quarter. Fisher Asset Management LLC bought a new stake in shares of Veeva Systems during the fourth quarter valued at approximately $227,000. Optimize Financial Inc increased its position in shares of Veeva Systems by 1.4% during the fourth quarter. Optimize Financial Inc now owns 5,139 shares of the technology company’s stock valued at $1,147,000 after acquiring an additional 72 shares in the last quarter. Finally, Legal & General Group Plc increased its position in shares of Veeva Systems by 8.4% during the fourth quarter. Legal & General Group Plc now owns 1,018,505 shares of the technology company’s stock valued at $227,361,000 after acquiring an additional 78,621 shares in the last quarter. Institutional investors own 88.20% of the company’s stock.

Analyst Ratings Changes

VEEV has been the subject of a number of research analyst reports. TD Cowen cut their target price on shares of Veeva Systems from $380.00 to $300.00 and set a “buy” rating for the company in a research report on Thursday, March 5th. Morgan Stanley lifted their target price on shares of Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 5th. Stifel Nicolaus boosted their price objective on shares of Veeva Systems from $212.00 to $245.00 and gave the company a “buy” rating in a research report on Thursday, March 5th. Piper Sandler cut their price objective on shares of Veeva Systems from $355.00 to $285.00 and set an “overweight” rating for the company in a research report on Thursday, March 5th. Finally, Canaccord Genuity Group lowered their target price on shares of Veeva Systems from $280.00 to $235.00 and set a “hold” rating on the stock in a research note on Thursday, March 5th. Sixteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $276.52.

Key Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva said Kindeva is adopting Veeva Quality Cloud to unify manufacturing operations across its global network, highlighting another enterprise customer win and potential for recurring software revenue. Veeva Quality Cloud Advances Manufacturing Operations for Kindeva
• Positive Sentiment: Teva Pharmaceuticals committed to Veeva Vault CRM globally, a meaningful commercial deal that supports Veeva’s customer expansion in pharma. Teva Pharmaceuticals Commits to Veeva Vault CRM
• Positive Sentiment: Merck KGaA, Darmstadt, Germany also selected Veeva Vault CRM worldwide, further validating Veeva’s platform and suggesting healthy enterprise adoption trends. Merck KGaA, Darmstadt, Germany Selects Veeva Vault CRM Worldwide
• Positive Sentiment: Veeva launched Falcon, an agentic platform for drug development workflows, which could strengthen its AI story and expand the value of its Development Cloud products. Veeva Announces Falcon, an Agentic Platform and Standard Agents to Deliver Agentic Labor in Drug Development
• Neutral Sentiment: Veeva was highlighted in a Zacks note as a trending stock and another report said analysts rate it a “Moderate Buy,” which may support investor interest but does not change fundamentals by itself. Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It

Veeva Systems Stock Up 3.6%

Shares of VEEV stock opened at $164.26 on Friday. The stock has a market cap of $26.83 billion, a P/E ratio of 30.36, a PEG ratio of 0.70 and a beta of 0.92. Veeva Systems Inc. has a 52 week low of $148.05 and a 52 week high of $310.50. The company’s fifty day simple moving average is $166.59 and its two-hundred day simple moving average is $199.95.

Veeva Systems (NYSE:VEEV) last issued its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The firm had revenue of $835.95 million for the quarter, compared to analysts’ expectations of $810.95 million. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The business’s revenue was up 16.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, analysts anticipate that Veeva Systems Inc. will post 6.45 EPS for the current fiscal year.

Insiders Place Their Bets

In other Veeva Systems news, Director Priscilla Hung sold 750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total transaction of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares in the company, valued at $506,296.92. This trade represents a 18.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by corporate insiders.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.